knowledge -WSS

knowledge

author：hotspot 2025-10-01 04:11:30 - browse：51

Photograph of Glaxo Smith Kline headquarters in London for a story on multiple myeloma cancer treatment ahead of the 2024 ASCO conference — JUSTIN TALLIS/AFP via Getty Images

LONDON — The resurrection of a GSK blood cancer drug — which the company withdrew from the U.S. market not even two years ago after it failed a key study — is taking its next step forward.

At the annual American Society of Clinical Oncology conference in Chicago, researchers on Sunday are presenting trial data showing that the drug, called Blenrep, outperformed a standard therapeutic approach when combined with another medicine in patients with multiple myeloma. It’s the second positive study for Blenrep in myeloma in recent months, and next up could be a return to regulatory agencies to get the drug re-approved.

In an interview, Hesham Abdullah, GSK’s oncology research leader, said the company planned to submit Blenrep to regulators by the end of the year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Here's how to stay safe from wildfire smoke amid reduced air quality

WSS

Meta looks to target Twitter with a rival app called Threads

Grail is spending more than ever lobbying Congress

Here's how to stay safe from wildfire smoke amid reduced air quality

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Here's how to stay safe from wildfire smoke amid reduced air quality

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

How one medical school became remarkably diverse

Community addresses injustice for Long Island mothers

Moonlake's readout produced a cash windfall. Risks remain

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Novavax promises a turnaround & Lilly roils the obesity market

Ukrainian soldiers say they owe lives to US

Malaria cases in Florida and Texas: Here’s what you need to know

When is a doctor not a doctor? Try when patients address women doctors

Trump demands the U.S. pay no more for drugs than other countries … again

Eating disorder hotline's move to chatbot carried cost for volunteers

knowledge

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Eating disorder hotline's move to chatbot carried cost for volunteers

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Inside the fall of star MIT scientist David Sabatini

Community addresses injustice for Long Island mothers

Did the public have the right to know Arthur Ashe had AIDS?

knowledge

knowledge

hotspot

explore